News
Hot off the Press
Discover news about Xcellerant Ventures, portfolio companies and the industry landcape.
Xcellerant Ventures News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Portfolio Company News
Published Study Reflects Nanodropper’s Significant Impact on Eyedrop Waste Reduction
https://nanodropper.com/published-study-reflects-nanodroppers-significant-impact-on-eyedrop-waste-reduction/ Content origionally posted on Nanodropper's blog: Nanodropper, an ophthalmic device company that makes the eyedrop volume-reducing Nanodropper...
Anuncia Medical Inc. Announces Published Data with Promising Clinical Outcomes Using the ReFlow™ Ventricular System In-Line with Hydrocephalus Shunts
Content origionally posted on PR Newswire: https://www.prnewswire.com/news-releases/anuncia-medical-inc-announces-published-data-with-promising-clinical-outcomes-using-the-reflow-ventricular-system-in-line-with-hydrocephalus-shunts-301832020.html SCOTTSDALE,...
“Treating Spinal Fractures Better” with Dom Messerli, Founder of Lenoss Medical
Podcast was origionally posted by Greenlight Guru: https://www.angelinvestboston.com/dom-messerli-treating-spinal-fractures-better Spinal fractures from osteoporosis cause many to lose their independence. Industry veteran Dom Messerli has a better way of fixing the...
Tesis Biosciences Announces New Test That Can Identify Those in Most Danger from Covid-19
Orgionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-new-test-that-can-identify-those-in-most-danger-from-covid-19-301821712.html PHOENIX, May 11, 2023 /PRNewswire/ -- Tesis Biosciences, the leader in targeted genetic...
Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity
Article origionally posted on Business Wire: https://www.businesswire.com/news/home/20230503005191/en/Paragraf-Acquires-CRISPR-Chip-Developer-Cardea-Bio-Accelerating-CRISPR-QC%E2%80%99s-Business-Opportunity SAN DIEGO--(BUSINESS WIRE)--Today, CRISPR QC announces that...
Tesis Biosciences Announces a Novel Pharmacogenomics Test Enabling Precise, Personalized Response to Wide Range of Pharmaceuticals
Content origionally from PR Newswire: https://www.prnewswire.com/news-releases/tesis-biosciences-announces-a-novel-pharmacogenomics-test-enabling-precise-personalized-response-to-wide-range-of-pharmaceuticals-301802763.html PHOENIX, April 20, 2023 /PRNewswire/...
TruLite Health’s Workflow Integration Approved for Use in Epic EMR
Content origionally on TruLite Health's website: https://trulitehealth.com/trulite-healths-workflow-integration-approved-for-use-in-epic-emr/ TruLite Health announces the approval of its EMR workflow integration and available application distribution with Epic Systems...
CRISPR QC Announces Formation of Scientific Advisory Board with Rodolphe Barrangou, Gene Dantsker, Jared Carlson-Stevermer Joining; Kiana Aran to Lead
Press release origionally published on Business Wire: https://www.businesswire.com/news/home/20230410005125/en/CRISPR-QC-Announces-Formation-of-Scientific-Advisory-Board-with-Rodolphe-Barrangou-Gene-Dantsker-Jared-Carlson-Stevermer-Joining-Kiana-Aran-to-Lead SAN...
Eric Schmidt, O.D., Explains Why Nanodropper Was Right For His Clinic Network
Content origionally on the Nanodropper blog: https://nanodropper.com/eric-schmidt-o-d-explains-why-nanodropper-was-right-for-his-clinic-network/ When renowned glaucoma specialist Dr. Eric Schmidt first encountered Nanodropper, his skepticism was high. Dr. Schmidt is...
CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List
This press release was origionally on Business Wire: https://www.businesswire.com/news/home/20230405005343/en/CRISPR-QC-Co-founder-Kiana-Aran-Makes-Inc.%E2%80%99s-2023-Female-Founders-List SAN DIEGO--(BUSINESS WIRE)--CRISPR QC is proud to announce that co-founder...
CRISPR QC Developing Electronic Platform to Measure Gene Editing Performance
The blog was posted on CRISPR QC's website: https://www.crisprqc.com/post/genomeweb-interview-of-ross-bundy-crispr-qc-ceo With $1.6 million of seed funding recently added to its balance sheet, CRISPR QC is advancing the commercial development of its data analytics...
CRISPR QC Closes Seed Round at $1.6M and Appoints George Bonaros to Board of Directors
Press release origionally released on Business Wire:...
Why Xcellerant Ventures
We firmly believe that founders deserve more than just a check. In fact, investors should empower founds to help promote a vibrant ecosystem that allows groundbreaking ideas to enhance accessibility, efficiency, affordability, and quality of healthcare.
Futhermore, our GPs’ experience is unique and perfectly aligned with the needs of the market. They bring a combined experience of over seven decades in medical technologies, law, and entrepreneurship.
Through their personal experience, domain expertise, and unique network, they provide hands-on advice, education, and invaluable guidance to xcellerate startups and drive their success.
Founder Focus
We believe that the quality of the founders makes a huge difference in creating and fostering a successful partnership. We pick founders that are humble, willing to take advice, lead from the front, and are driven to change the world.
Moreover, we actively seek out founders and companies that have been overlooked by other venture capitalists, providing opportunities, expertise, and funding to individuals who have been traditionally underrepresented in the innovation economy.